What does CUSIP 29089Q105 represent in this 13F holders report?

CUSIP 29089Q105 is the security identifier for EBS - Emergent BioSolutions Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held EBS - Emergent BioSolutions Inc. - Common Stock in Q1 2021?

334 institutional investors reported EBS - Emergent BioSolutions Inc. - Common Stock for Q1 2021. Use the holders table for investor-level position and value details.

Emergent BioSolutions Inc. - Common Stock (EBS)

CUSIP: 29089Q105

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class: Equity / Common Stock
Shares outstanding: 51,688,294
Total 13F shares: 44,459,246
Share change: +669,386
Total reported value: $4,122,801,151
Put/Call ratio: 117%
Price per share: $92.91
Number of holders: 334
Value change: +$64,719,540
Number of buys: 158
Number of sells: 182

Quarterly Holders Quick Answers

What is CUSIP 29089Q105?
CUSIP 29089Q105 identifies EBS - Emergent BioSolutions Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2021
Previous quarter: Q4 2020

Recent filing periods for CUSIP 29089Q105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of EBS - Emergent BioSolutions Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	10%	5,276,948	$472,815,000	—	31 Dec 2020	13F
VANGUARD GROUP INC	13F	Company	9.3%	4,790,573	$429,236,000	—	31 Dec 2020	13F
Neuberger Berman Group LLC	13F	Company	6.2%	3,211,349	$287,205,000	—	31 Dec 2020	13F
STATE STREET CORP	13F	Company	4.2%	2,145,591	$192,245,000	—	31 Dec 2020	13F
EARNEST PARTNERS LLC	13F	Company	2.7%	1,390,735	$124,610,000	—	31 Dec 2020	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	2.1%	1,081,617	$96,913,000	—	31 Dec 2020	13F
Invesco Ltd.	13F	Company	2.1%	1,075,074	$96,326,000	—	31 Dec 2020	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	2%	1,036,814	$92,906,000	—	31 Dec 2020	13F
JANUS HENDERSON GROUP PLC	13F	Company	1.8%	944,064	$84,588,000	—	31 Dec 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	1.7%	900,615	$80,694,000	—	31 Dec 2020	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	1.7%	872,367	$78,164,000	—	31 Dec 2020	13F
NORTHERN TRUST CORP	13F	Company	1.6%	803,336	$71,980,000	—	31 Dec 2020	13F
SNYDER CAPITAL MANAGEMENT L P	13F	Company	1.4%	723,477	$64,824,000	—	31 Dec 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.3%	689,734	$61,800,000	—	31 Dec 2020	13F
VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P.	13F	Company	1.3%	657,766	$58,935,000	—	31 Dec 2020	13F
GW&K Investment Management, LLC	13F	Company	1.2%	629,181	$56,375,000	—	31 Dec 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	1.2%	600,086	$53,768,000	—	31 Dec 2020	13F
RICE HALL JAMES & ASSOCIATES, LLC	13F	Company	1.1%	587,727	$52,660,000	—	31 Dec 2020	13F
PALISADE CAPITAL MANAGEMENT, LP	13F	Company	1.1%	579,009	$51,879,000	—	31 Dec 2020	13F
EAGLE ASSET MANAGEMENT INC	13F	Company	1.1%	567,984	$50,891,000	—	31 Dec 2020	13F
NORGES BANK	13F	Company	1%	524,498	$46,995,000	—	31 Dec 2020	13F
Bank of New York Mellon Corp	13F	Company	1%	520,216	$46,610,000	—	31 Dec 2020	13F
Fisher Asset Management, LLC	13F	Company	0.94%	485,356	$43,488,000	—	31 Dec 2020	13F
EATON VANCE MANAGEMENT	13F	Company	0.88%	456,768	$40,927,000	—	31 Dec 2020	13F
ATLANTA CAPITAL MANAGEMENT CO L L C	13F	Company	0.86%	446,984	$40,050,000	—	31 Dec 2020	13F
FMR LLC	13F	Company	0.86%	443,479	$39,736,000	—	31 Dec 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.86%	443,297	$39,719,000	—	31 Dec 2020	13F
FRANKLIN RESOURCES INC	13F	Company	0.85%	440,117	$39,435,000	—	31 Dec 2020	13F
CARILLON TOWER ADVISERS, INC.	13F	Company	0.8%	411,186	$36,842,000	—	31 Dec 2020	13F
JENNISON ASSOCIATES LLC	13F	Company	0.76%	394,474	$35,345,000	—	31 Dec 2020	13F
PRUDENTIAL FINANCIAL INC	13F	Company	0.73%	375,848	$33,676,000	—	31 Dec 2020	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.71%	365,796	$32,775,000	—	31 Dec 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.71%	365,390	$32,739,000	—	31 Dec 2020	13F
LAZARD ASSET MANAGEMENT LLC	13F	Company	0.68%	349,324	$31,299,000	—	31 Dec 2020	13F
FULLER & THALER ASSET MANAGEMENT, INC.	13F	Company	0.55%	286,734	$25,691,000	—	31 Dec 2020	13F
SILVERCREST ASSET MANAGEMENT GROUP LLC	13F	Company	0.55%	282,684	$25,328,000	—	31 Dec 2020	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.5%	260,268	$23,320,000	—	31 Dec 2020	13F
ROYAL BANK OF CANADA	13F	Company	0.5%	258,673	$23,176,000	—	31 Dec 2020	13F
DEUTSCHE BANK AG\	13F	Company	0.46%	238,392	$21,359,000	—	31 Dec 2020	13F
FEDERATED HERMES, INC.	13F	Company	0.45%	230,855	$20,684,000	—	31 Dec 2020	13F
BAMCO INC /NY/	13F	Company	0.36%	185,000	$16,576,000	—	31 Dec 2020	13F
ROYCE & ASSOCIATES LP	13F	Company	0.36%	183,582	$16,449,000	—	31 Dec 2020	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.35%	182,088	$16,315,000	—	31 Dec 2020	13F
JPMORGAN CHASE & CO	13F	Company	0.35%	181,816	$16,291,000	—	31 Dec 2020	13F
PEREGRINE CAPITAL MANAGEMENT LLC	13F	Company	0.34%	176,891	$15,849,000	—	31 Dec 2020	13F
Clark Capital Management Group, Inc.	13F	Company	0.31%	161,986	$14,514,000	—	31 Dec 2020	13F
Hillcrest Asset Management LLC	13F	Company	0.31%	161,428	$14,464,000	—	31 Dec 2020	13F
MORGAN STANLEY	13F	Company	0.3%	157,394	$14,103,000	—	31 Dec 2020	13F
SCOUT INVESTMENTS, INC.	13F	Company	0.3%	155,200	$13,906,000	—	31 Dec 2020	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.3%	153,244	$13,731,000	—	31 Dec 2020	13F

Institutional Holders of Emergent BioSolutions Inc. - Common Stock (EBS) as of Q1 2021

As of 31 Mar 2021, Emergent BioSolutions Inc. - Common Stock (EBS) was held by 334 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 44,459,246 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, Neuberger Berman Group LLC, JANUS HENDERSON GROUP PLC, STATE STREET CORP, EARNEST PARTNERS LLC, MANUFACTURERS LIFE INSURANCE COMPANY, THE, DIMENSIONAL FUND ADVISORS LP, Invesco Ltd., and GEODE CAPITAL MANAGEMENT, LLC. This page lists 334 institutional shareholders reporting positions in this security for the Q1 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders

350

Q1 2021 holders

334

Holder diff

-16

Investor	Q4 2020 Shares	Q1 2021 Shares	Share Diff	Share Chg %	Q4 2020 Value $	Q1 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.